Sumitomo Pharma America Presents New Data on Vibegron at the 2025 American Urological Association Annual Meeting
Press Releases
Sumitomo Pharma America  
April 29, 2025

Sumitomo Pharma America Presents New Data on Vibegron at the 2025 American Urological Association Annual Meeting

– Data include results from COURAGE Phase 3 and COMPOSUR Phase 4 studies of vibegron (GEMTESA®) –

avatar profile Olean Times Herald

Olean Times Herald


Local & Social